SARC Clinical Trials Update: CCS, EHE, GIST, MPNST & New Programs | SARC at ASCO 2026

This session provides a comprehensive update on SARC clinical trials, research programs, and upcoming initiatives in sarcoma drug development. Highlights include updates on active, completed, and planned clinical trials, as well as new program initiatives aimed at accelerating sarcoma research globally. Clinical trial updates include: SARC041: Abemaciclib vs placebo in dedifferentiated liposarcoma (DDLPS) SARC044: Bezuclastinib with sunitinib in GIST SARC045: Tebentafusp in advanced clear cell sarcoma (CCS) SARC046: Nab-sirolimus in epithelioid hemangioendothelioma (EHE) SARC048: Neoadjuvant doxorubicin & ifosfamide in soft tissue sarcoma SARC049: Zanzalintinib in MPNST Additional highlights: SARC committee and global collaboration updates Sarcoma symposia and SARCTALK podcast expansion NextGen Advisory Board initiatives Patient advocacy and AYA survivor engagement programs This session emphasizes the collaborative infrastructure driving sarcoma clinical research forward.